A61Q19/06

COSMETIC COMPOSITION
20200113800 · 2020-04-16 ·

Cosmetics or similar dermatological or pharmaceutical preparations containing materials, or derivatives thereof, of indole-3-carbinol for the intended use of improving the appearance of the skin

COSMETIC COMPOSITION
20200113800 · 2020-04-16 ·

Cosmetics or similar dermatological or pharmaceutical preparations containing materials, or derivatives thereof, of indole-3-carbinol for the intended use of improving the appearance of the skin

ALCOHOL-BASED COMPOSITIONS AND USES THEREOF
20200113849 · 2020-04-16 ·

This disclosure relates to a method of reducing a fat deposit comprising injecting an alcohol-containing pharmaceutical composition into the fat deposit. The method may be effective in improving the appearance of or reducing the weight or volume of the fat deposit.

Pharmaceutical composition for reducing local fat and uses thereof
10610496 · 2020-04-07 · ·

The present invention provides a pharmaceutical composition for reducing localized fat, comprising drug-containing micelles made of surfactants, and curcumin encapsulated in said drug-containing micelles. This pharmaceutical composition for reducing localized fat can reduce the fat at the administration site, and has the advantages of high stability, high bioavailability for fat tissue, few side effects, and sustained release.

Pharmaceutical composition for reducing local fat and uses thereof
10610496 · 2020-04-07 · ·

The present invention provides a pharmaceutical composition for reducing localized fat, comprising drug-containing micelles made of surfactants, and curcumin encapsulated in said drug-containing micelles. This pharmaceutical composition for reducing localized fat can reduce the fat at the administration site, and has the advantages of high stability, high bioavailability for fat tissue, few side effects, and sustained release.

Skin care compositions and methods of use thereof

The present disclosure provides a mixture of sugar apple and rosemary extracts, optionally in combination with prickly ash extract, for use as skin care compositions.

Skin care compositions and methods of use thereof

The present disclosure provides a mixture of sugar apple and rosemary extracts, optionally in combination with prickly ash extract, for use as skin care compositions.

Methods and compositions for treating striae distensae

The present invention relates generally to methods of use and compositions useful for treating, preventing, and or reducing the appearance of stretch marks. The composition includes a combination of vegetable amino acids, Myrciaria dubia fruit extract, Peucedanum graveolens extract, and tetrahexyldecyl ascorbate.

Methods and compositions for treating striae distensae

The present invention relates generally to methods of use and compositions useful for treating, preventing, and or reducing the appearance of stretch marks. The composition includes a combination of vegetable amino acids, Myrciaria dubia fruit extract, Peucedanum graveolens extract, and tetrahexyldecyl ascorbate.

USE OF A NEPHELIUM LAPPACEUM EXTRACT FOR INCREASING THE FIRMNESS OF THE SKIN AND/OR OF THE MUCOUS MEMBRANES

The invention relates to the use of various extracts of the Nephelium lappaceum plant for increasing the firmness and/or elasticity of the skin and/or mucous membranes, by increasing type I and/or type V collagen and/or LOX-L, fibulin-5, emiline-1 and/or fibrillin-1 gene and/or protein expression, and/or by decreasing CYR61 expression, in the skin and mucous membranes. Another subject of the invention relates to the use of said extracts in a cosmetic composition comprising at least one cosmetically acceptable excipient. Another subject further relates to a cosmetic care method comprising the application of the extract according to the invention or of a cosmetic composition comprising it, for increasing the firmness and/or elasticity of the skin and/or mucous membranes, by increasing type I and/or type V collagen, fibrillin-1 and/or LOX-L, fibulin-5, emiline-1 and/or fibrillin-1 gene and/or protein expression, and/or by decreasing CYR61 expression, in the skin and mucous membranes. A final subject relates to an N. lappaceum extract for use thereof, alone or in a dermatological or pharmaceutical composition, in the prevention and/or treatment of pathological conditions involving a loss of collagen protein and/or gene expression and/or a pathological loss of firmness of the skin and/or mucus membranes, such as rosacea and telangiectasia.